RB-W: Zawiadomienie od osoby zobowiązanej

· 1 grudnia 2022

This document is a corrected MAR Article 19 insider transaction notification by Mariusz Nowak, Chairman of BioMaxima's Supervisory Board. The transaction involves acquisition of 1,892 BMX shares executed on 2022-11-30 at an average price of 23.1186 PLN, totaling approximately 43,716.68 PLN (~€10,700). The correction addresses an error in the original filing regarding trading venue. The transaction represents deliberate share accumulation by a senior board member, with purchases distributed across six price points (22.95–23.30 PLN), suggesting methodical buying over the trading session. At the time (Nov 2022), this constituted a bullish insider signal. However, current stock price of 11.8 PLN (52-week range 10.7–15.3) indicates the stock has declined ~49% since purchase, raising questions about company fundamentals and whether the board member's confidence was misplaced or if broader sector headwinds affected the healthcare stock. The corrected filing itself presents a minor compliance concern—the original report contained an error in venue designation that required amendment. This is not unusual but worth noting during compliance review.

Kluczowe dane finansowe

Transaction Type

Chairman of Supervisory Board buy signal

Share Acquisition (Nabycie)
Shares Purchased

Accumulated across 6 separate orders at different price points

1,892 shares
Average Purchase Price

Range 22.95–23.30 PLN; current price 11.8 PLN represents -49% decline

23.12 PLN/share
Total Transaction Value

Modest position size relative to public market cap

43,716.68 PLN (~€10,700)
Transaction Date

Reported with correction for venue information

2022-11-30
Insider Role

Senior governance role with fiduciary responsibility

Przewodniczący Rady Nadzorczej (Supervisory Board Chairman)
Report Type

Original filing contained incorrect transaction venue; amended to XWAR–GPW

Zmiana (Amendment/Correction)
Current Stock Price

52-week range 10.7–15.3 PLN; -49% vs purchase price

11.8 PLN
SMA Alignment

Both near-term and long-term averages above current price, indicating downtrend recovery area

SMA20: 11.74, SMA200: 11.84
Filing Venue

Primary listing; correction was venue specification error in original report

XWAR – GPW (Warsaw Stock Exchange)

Oryginalny dokument